Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
Cheng, Yao
Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. [electronic resource] - International journal of pharmaceutics Jul 2018 - 261-273 p. digital
Publication Type: Journal Article
1873-3476
10.1016/j.ijpharm.2018.05.007 doi
Animals
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Apoptosis--drug effects
Carcinoma, Hepatocellular--drug therapy
Cisplatin--administration & dosage
Curcumin--administration & dosage
Dose-Response Relationship, Drug
Drug Compounding
Drug Liberation
Drug Synergism
Female
Hep G2 Cells
Humans
Lipids--chemistry
Liposomes
Liver Neoplasms--drug therapy
Mice, Inbred BALB C
Mice, Nude
Nanoparticles
Nanotechnology
Oxidative Stress--drug effects
Particle Size
Reactive Oxygen Species--metabolism
Technology, Pharmaceutical--methods
Tissue Distribution
Xenograft Model Antitumor Assays
Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. [electronic resource] - International journal of pharmaceutics Jul 2018 - 261-273 p. digital
Publication Type: Journal Article
1873-3476
10.1016/j.ijpharm.2018.05.007 doi
Animals
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Apoptosis--drug effects
Carcinoma, Hepatocellular--drug therapy
Cisplatin--administration & dosage
Curcumin--administration & dosage
Dose-Response Relationship, Drug
Drug Compounding
Drug Liberation
Drug Synergism
Female
Hep G2 Cells
Humans
Lipids--chemistry
Liposomes
Liver Neoplasms--drug therapy
Mice, Inbred BALB C
Mice, Nude
Nanoparticles
Nanotechnology
Oxidative Stress--drug effects
Particle Size
Reactive Oxygen Species--metabolism
Technology, Pharmaceutical--methods
Tissue Distribution
Xenograft Model Antitumor Assays